MILESTONE PHARMACEUTICALS INC.

Profile

Company Names

MILESTONE PHARMACEUTICALS INC.

Addresses

1111 DR. FREDERIK-PHILIPS BLVD, SUITE 420, MONTREAL, A8 H4M 2X6

1111 DR. FREDERIK-PHILIPS BLVD., SUITE 420, MONTREAL, A8 H4M 2X6

6100 ROYALMOUNT AVENUE, MONTREAL, A8 H4P 2R2

Phone Numbers

(514) 336-0444
(514) 496-3220

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

CANADA (FEDERAL LEVEL)

Total Amount Raised:

$91,323,943.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2018-10-15 
$80,000,000.00 
$80,000,000.00 
$0.00 
Equity 
3
2017-07-21 
$6,880,072.00 
$6,880,072.00 
$0.00 
Equity 
2
2015-06-03 
$3,848,369.00 
$9,406,593.00 
$5,558,224.00 
Equity 
1
2011-05-31 
$595,502.00 
$595,502.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
NATHALIE 
 
BEAUREGARD 
EXECUTIVE OFFICER
MILESTONE PHARMACEUTICALS INC.
CEDRIC 
 
BISSON 
DIRECTOR
MILESTONE PHARMACEUTICALS INC.
MARCO 
 
BOORSMA 
DIRECTOR
MILESTONE PHARMACEUTICALS INC.
ELA 
 
BORENSTEIN 
DIRECTOR
MILESTONE PHARMACEUTICALS INC.
BENJAMIN 
 
COWEN 
EXECUTIVE OFFICER
MILESTONE PHARMACEUTICALS INC.
PHILIPPE 
 
DOUVILLE 
EXECUTIVE OFFICER, DIRECTOR
MILESTONE PHARMACEUTICALS INC.
DOMINIC 
 
JAIKARAN 
DIRECTOR
MILESTONE PHARMACEUTICALS INC.
NILESH 
 
KUMAR 
DIRECTOR
AUXOGYN INC   |  AUXOGYN, INC.   |  TARVEDA THERAPEUTICS, INC.   |  RGENIX, INC.   |  CIRIUS THERAPEUTICS, INC.   |  MILESTONE PHARMACEUTICALS INC.   |  MORPHIC HOLDING, LLC
PHILIPPE 
 
LAMARRE 
EXECUTIVE OFFICER
MILESTONE PHARMACEUTICALS INC.
VINCENT 
 
LESAGE 
EXECUTIVE OFFICER
MILESTONE PHARMACEUTICALS INC.
DEBRA 
 
LIEBERT 
DIRECTOR
MILESTONE PHARMACEUTICALS INC.
ERIC 
 
LINSLEY 
DIRECTOR
BAROSENSE INC   |  CEQUENT PHARMACEUTICALS INC   |  MILESTONE PHARMACEUTICALS INC.   |  ENVISIA THERAPEUTICS, INC.   |  CEREIUS, INC.
DION 
 
MADSEN 
DIRECTOR
ELIXIR PHARMACEUTICALS, INC.   |  HALOSOURCE INC   |  SURFACE LOGIX INC   |  ON-Q-ITY, INC.   |  ZYMEWORKS INC.   |  MILESTONE PHARMACEUTICALS INC.
MARTIN 
 
MAGUIRE 
EXECUTIVE OFFICER
MILESTONE PHARMACEUTICALS INC.   |  COMMUNITY FIRST INC
LORENZ 
 
MULLER 
EXECUTIVE OFFICER
MILESTONE PHARMACEUTICALS INC.
JEFF 
 
NELSON 
EXECUTIVE OFFICER
LIFTSEAT CORP   |  MILESTONE PHARMACEUTICALS INC.
JOSEPH 
G. 
OLIVETO 
EXECUTIVE OFFICER, DIRECTOR
MILESTONE PHARMACEUTICALS INC.
HARISH 
 
PIMPLASKAR 
EXECUTIVE OFFICER
MILESTONE PHARMACEUTICALS INC.
FRANCIS 
 
PLAT 
EXECUTIVE OFFICER
MILESTONE PHARMACEUTICALS INC.
YVES 
 
ROSCONI 
DIRECTOR
MILESTONE PHARMACEUTICALS INC.   |  LAURENT PHARMACEUTICALS INC.
GUY 
 
ROUSSEAU 
EXECUTIVE OFFICER
MILESTONE PHARMACEUTICALS INC.
PAUL 
 
TRUEX 
EXECUTIVE OFFICER, DIRECTOR
TRIUS THERAPEUTICS INC   |  EIGER BIOPHARMACEUTICALS INC   |  MILESTONE PHARMACEUTICALS INC.
SCOTT 
 
WEINER 
DIRECTOR
MILESTONE PHARMACEUTICALS INC.   |  TELEPRO-DIRECT, INC.   |  MAKER-S ROW, INC.   |  ROTATION MEDICAL INC   |  RENEO PHARMACEUTICALS, INC.   |  APOLLO U.S. REAL ESTATE PARTNERS III (TE), L.P.   |  APOLLO U.S. REAL ESTATE PARTNERS III (OFFSHORE), L.P.   |  APOLLO U.S. REAL ESTATE FUND III, L.P.
DOUGLAS 
 
WIGHT 
EXECUTIVE OFFICER
MILESTONE PHARMACEUTICALS INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2018-10-26
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-10-15 
2017-07-25
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-07-21 
2015-06-15
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-06-03 
2011-06-14
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-05-31 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#